Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001883850-21-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-03 | 2021-11-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $642.52 | -100 | 23.1K | -0.4% | -$64.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | S | D | 8 | $647.00 | 23,091 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-01 | S | D | 5 | $646.37 | 23,099 | D | — | — | (F9) Represents volume-weighted average price of sales of 5 shares of Company stock on November 1, 2021 at prices ranging from $646.00 to $646.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-11-01 | S | D | 15 | $645.41 | 23,104 | D | — | — | (F8) Represents volume-weighted average price of sales of 15 shares of Company stock on November 1, 2021 at prices ranging from $645.01 to $645.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-11-01 | S | D | 9 | $644.62 | 23,119 | D | — | — | (F7) Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $644.21 to $644.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-11-01 | S | D | 1 | $643.82 | 23,128 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-01 | S | D | 19 | $641.52 | 23,138 | D | — | — | (F5) Represents volume-weighted average price of sales of 19 shares of Company stock on November 1, 2021 at prices ranging from $641.11 to $641.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-11-01 | S | D | 17 | $640.08 | 23,157 | D | — | — | (F4) Represents volume-weighted average price of sales of 17 shares of Company stock on November 1, 2021 at prices ranging from $640.00 to $640.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-11-01 | S | D | 11 | $639.52 | 23,174 | D | — | — | (F3) Represents volume-weighted average price of sales of 11 shares of Company stock on November 1, 2021 at prices ranging from $639.17 to $639.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-11-01 | S | D | 6 | $638.62 | 23,185 | D | — | — | (F2) Represents volume-weighted average price of sales of 6 shares of Company stock on November 1, 2021 at prices ranging from $638.57 to $638.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-11-01 | S | D | 9 | $642.28 | 23,129 | D | — | — | (F6) Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $642.00 to $642.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price. |